Concepts (276)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with KEVIN FISHER's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that KEVIN FISHER has written about over time.
Matrix Metalloproteinase 14Carcinoma, PapillaryProto-Oncogene Proteins B-rafMelanomaCarcinoma, Non-Small-Cell LungThyroid NeoplasmsBiomarkers, TumorMutationSarcoma, MyeloidMediastinal NeoplasmsLeukemia, Megakaryoblastic, AcuteBlood Platelet DisordersRepressor ProteinsLymphoma, Large-Cell, AnaplasticLymphoma, Large B-Cell, DiffuseApoptosis Regulatory ProteinsBrain AbscessNeutropeniaProto-Oncogene Proteins c-ets
To see the data from this visualization as text,
click here.
Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
Matrix Metalloproteinase 14 | 4 | 2006 | 2010 | January 2009 |
Carcinoma, Papillary | 2 | 2013 | 2013 | June 2013 |
Proto-Oncogene Proteins B-raf | 7 | 2013 | 2017 | January 2015 |
Melanoma | 6 | 2014 | 2016 | February 2015 |
Carcinoma, Non-Small-Cell Lung | 3 | 2014 | 2016 | April 2015 |
Thyroid Neoplasms | 3 | 2013 | 2018 | August 2015 |
Biomarkers, Tumor | 13 | 2012 | 2024 | January 2017 |
Mutation | 15 | 2014 | 2023 | May 2018 |
Sarcoma, Myeloid | 1 | 2019 | 2019 | November 2019 |
Mediastinal Neoplasms | 1 | 2020 | 2020 | August 2020 |
Leukemia, Megakaryoblastic, Acute | 2 | 2020 | 2022 | September 2021 |
Blood Platelet Disorders | 1 | 2022 | 2022 | February 2022 |
Repressor Proteins | 4 | 2019 | 2024 | July 2022 |
Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 2022 | July 2022 |
Lymphoma, Large B-Cell, Diffuse | 2 | 2022 | 2024 | May 2023 |
Apoptosis Regulatory Proteins | 1 | 2024 | 2024 | August 2024 |
Brain Abscess | 1 | 2024 | 2024 | August 2024 |
Neutropenia | 1 | 2024 | 2024 | August 2024 |
Proto-Oncogene Proteins c-ets | 1 | 2024 | 2024 | August 2024 |
To return to the timeline,
click here.